TABLE 4.

Results in the Area With Screening Versus the Area Without Screening (Median [Range])

Screening (n = 7 Males/8 Females)Without Screening (n = 10 Males/9 Females)Significance*
Prevalence1:11 7781:11 753
Day heel puncture5 (2–30)5 (3–8)
Day admission6 (0–9)9.5 (0–95)P = .08
Day start therapy7 (1–31)14 (0–115)P < .02
Serum sodium (mmol/L)135.0 (129–142)127.0 (101–142)P < .004
Serum sodium (%) <135 mmol/L4080
Serum potassium (mmol/L)5.9 (4.1–8.1)7.6 (4.9–9.7)P < .02
Serum potassium (%) ≥5.5 mmol/L6580
Days of hospitalization in males**7.0 (5–14)13 (6–24)
17OHP in heel-prick blood555 (180–1238)867 (231–1230)
  • * Mann-Whitney (2-tailed).

  • ** Females were excluded from the calculation because hospital admission of females with ambiguous genitalia was sometimes extended for genital surgery.